1. Lipids
  2. Glycerophospholipids

Glycerophospholipids

Glycerophospholipids (309):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-W040193
    DSPC 816-94-4 99.95%
    DSPC (1,2-Distearoyl-sn-glycero-3-phosphorylcholine) is a cylindrical-shaped lipid. DSPC is used to synthesize liposomes, and is the lipid component in the lipid nanoparticle (LNP) system.
    DSPC
  • HY-112005
    DOPE 4004-05-1 99.96%
    DOPE (Dioleoylphosphatidylethanolamine) is a neutral helper lipid for cationic liposome and combines with cationic phospholipids to improve transfection efficiency of naked siRNA.
    DOPE
  • HY-107614
    1-Oleoyl lysophosphatidic acid sodium 325465-93-8 99.96%
    1-Oleoyl lysophosphatidic acid (1-Oleoyl-sn-glycero-3-phosphate) sodium, a potent bioactive phospholipid, is a LPA receptor activator. 1-Oleoyl lysophosphatidic acid sodium can promote mitosis by inducing DNA synthesis. 1-Oleoyl lysophosphatidic acid sodium is also involved in normal and pathological emotional responses, including anxiety and depression.
    1-Oleoyl lysophosphatidic acid sodium
  • HY-108635
    C16-PAF 74389-68-7 99.86%
    C16-PAF (PAF (C16)), a phospholipid mediator, is a platelet-activating factor and ligand for PAF G-protein-coupled receptor (PAFR). C16-PAF exhibits anti-apoptotic effect and inhibits caspase-dependent death by activating the PAFR. C16-PAF is a potent MAPK and MEK/ERK activator. C16-PAF induces increased vascular permeability.
    C16-PAF
  • HY-109506
    DPPC 63-89-8 99.91%
    DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice.
    DPPC
  • HY-148978A
    18:0,18:1 PS 124262-93-7 99.95%
    18:0,18:1 PS is the dominant phosphatidylserine subtype in cells, exosomes and HIV particles. It is abundant in the brain and is essential for maintaining membrane structure, lipid raft organization and intracellular trafficking. 18:0,18:1 PS mediates interleaflet membrane coupling through cholesterol-dependent interactions with very long-chain sphingolipids, and can induce the clustering of glycosylphosphatidylinositol-anchored proteins. In addition, clusters formed by the binding of 18:0,18:1 PS to cholesterol not only facilitate the proper distribution of cholesterol in lipid bilayers, but also effectively protect cholesterol from oxidative damage.
    18:0,18:1 PS
  • HY-113029
    LysoPC (20:3(5Z,8Z,11Z)) 1199257-41-4
    LysoPC 20:3(5Z,8Z,11Z) is a lysophosphatidylcholine. LysoPC 20:3(5Z,8Z,11Z) can be used as a biomarker for acute aortic dissection.
    LysoPC (20:3(5Z,8Z,11Z))
  • HY-113001
    LysoPC(20:3(8Z,11Z,14Z)/0:0) 1006703-11-2
    LysoPC (20:3 (8Z,11Z,14Z)/0:0) is a bioactive lysophosphatidylcholine. LysoPC (20:3 (8Z,11Z,14Z)/0:0) is applicable to research related to inflammation and autoimmune diseases.
    LysoPC(20:3(8Z,11Z,14Z)/0:0)
  • HY-113424A
    1,2-Dioleoyl-sn-glycero-3-phosphocholine 4235-95-4 99.93%
    1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) is a phospholipid and is commonly used alone, or with other components, in the generation of micelles, liposomes, and other types of artificial membranes.
    1,2-Dioleoyl-sn-glycero-3-phosphocholine
  • HY-139414
    Lysophosphatidylcholines 9008-30-4 99.9%
    Lysophosphatidylcholines is an orally active lysolipid and a component of oxidized low density lipoprotein (LDL). Lysophosphatidylcholines induces cell injury, the production of IL-1β and apoptosis. Lysophosphatidylcholines has a proactive effect on sepsis.
    Lysophosphatidylcholines
  • HY-137862
    1-Oleoyl lysophosphatidic acid 65528-98-5 99.96%
    1-Oleoyl lysophosphatidic acid (1-Oleoyl-sn-glycero-3-phosphate) is an abundant lysophosphatidic acid (LPA) species with high biological activity due to its strong affinity for the LPA receptors. 1-Oleoyl lysophosphatidic acid is commonly used in most laboratories as a reagent for LPA receptor activation. 1-Oleoyl lysophosphatidic acid increases SRE-driven β-galactosidase activity.
    1-Oleoyl lysophosphatidic acid
  • HY-130462
    1-Palmitoyl-2-oleoyl-sn-glycero-3-PC 26853-31-6 99.96%
    1-Palmitoyl-2-oleoyl-sn-glycero-3-PC (POPC), a phospholipid, is a major component of biological membranes. 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC is used for the preparation of liposomes and studying the properties of lipid bilayers.
    1-Palmitoyl-2-oleoyl-sn-glycero-3-PC
  • HY-125783
    1-Palmitoyl-sn-glycero-3-phosphocholine 17364-16-8 99.92%
    1-Palmitoyl-sn-glycero-3-phosphocholine (16:0 Lyso PC) is an abundant lysophosphatidylcholine. 1-Palmitoyl-sn-glycero-3-phosphocholine exhibits proinflammatory activity. 1-Palmitoyl-sn-glycero-3-phosphocholine can be used in the study of atherosclerosis.
    1-Palmitoyl-sn-glycero-3-phosphocholine
  • HY-109541
    Colfosceril miristate 18194-24-6 99.96%
    Colfosceril miristate (DMPC) is a synthetic phospholipid. Colfosceril miristate has antiproliferative effects on various tumors. Colfosceril miristate is used to study lipid monolayers, bilayers and drug delivery.
    Colfosceril miristate
  • HY-W251428
    Phosphatidylglycerols (egg) sodium salt 383907-64-0 99.53%
    Phosphatidylglycerols (PG) is a selective inhibitor targeting the TLR4 accessory protein CD14/MD-2 complex, inhibiting LPS or virus (such as RSV)-mediated inflammatory signaling pathways through competitive binding. Phosphatidylglycerols directly bind to viral particles to block infection, inhibit COX-2 expression to reduce the release of inflammatory factors (IL-6, IL-8), and improve oxidative stress by regulating mitochondrial membrane phospholipid remodeling. Phosphatidylglycerols can be taken orally or by inhalation and can be used in the study of chronic inflammatory diseases (such as atherosclerosis) and respiratory viral infections (such as RSV).
    Phosphatidylglycerols (egg) sodium salt
  • HY-N9410
    Lysophosphatidylcholine 18:2 22252-07-9 99.12%
    Lysophosphatidylcholine 18:2 (1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC), a lysophospholipid, is a potential biomarker identified from insulin resistance (IR) polycystic ovary syndrome (PCOS). Low plasma Lysophosphatidylcholine 18:2 also has been shown to predict impaired glucose tolerance, insulin resistance, type 2 diabetes, coronary artery disease, and memory impairment.
    Lysophosphatidylcholine 18:2
  • HY-125771
    1-Stearoyl-sn-glycero-3-phosphocholine 19420-57-6 99.53%
    1-Stearoyl-sn-glycero-3-phosphocholine is a lysophosphatidylcholine that inhibits HDAC3 activity and phosphorylation of STAT3 in K562 cells. 1-Stearoyl-sn-glycero-3-phosphocholine induces apoptosis and exhibits anticancer activity in chronic myelogenous leukemia (CML) K562 cells.
    1-Stearoyl-sn-glycero-3-phosphocholine
  • HY-A0183
    Phosphatidylserine 1446756-47-3 ≥98.0%
    Phosphatidylserine (Phospholipids) is a well-conserved anti-inflammatory and immunosuppressive signal. Phosphatidylserine is involved in membrane translocation and the activation of protein kinase C, participating in Akt signaling through its interaction with PIP3. The local exposure of Phosphatidylserine can interact with complement and other proteins, promoting microglial phagocytosis during critical periods of synaptic refinement. Phosphatidylserine can promote blood coagulation in the extracellular environment and acts as a "eat me" signal to clear out apoptotic cells. Phosphatidylserine can suppress inflammation in tissues by inducing TGF-β secretion and inhibiting immune responses.
    Phosphatidylserine
  • HY-113123
    LysoPC(14:0/0:0) 20559-16-4 99.84%
    LysoPC(14:0/0:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. LysoPC(14:0/0:0) has potent antispasmodic effect.
    LysoPC(14:0/0:0)
  • HY-W140439
    1-Oleoyl-sn-glycero-3-phosphocholine 19420-56-5 99.58%
    1-Oleoyl-sn-glycero-3-phosphocholine (18:1 Lyso PC), a lysophospholipid, is a GPR82 inhibitor. 1-Oleoyl-sn-glycero-3-phosphocholine abrogates constitutive Gi-coupled GPR82 activity, shifts active/inactive equilibrium to inactive, suppresses Gi protein activation, increases cAMP production, and decreases GTPγS binding to Gαi proteins. 1-Oleoyl-sn-glycero-3-phosphocholine contributes to adipocyte lipolysis regulation.1-Oleoyl-sn-glycero-3-phosphocholine exhibits reduced serum levels in mouse models of steatohepatitis, linked to hepatic Lpcat 1-4 up-regulation.
    1-Oleoyl-sn-glycero-3-phosphocholine